Chronic Sinusitis. Chronic sinusitis, unspecified
Conditions
Interventions
Intervention 1: Group A) propofol (50/mg/kg/min) + remifentanyl (0/1 mg/kg/min) group. Intervention 2: Group B) Insofluran group
(0-0/6%).
Treatment - Drugs
Group A) propofol (50/mg/kg/min) + remifentanyl (0/1 mg/kg/min) group
Group B) Insofluran group
(0-0/6%)
Sponsors
Guilan University of Medical Sciences, Vice Chancellor for Research
Eligibility
Sex/Gender
All
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients candidated for elective endoscopic sinus surgery (15-45yr); ASA class I,II; Patients with completely treated nose and sinus infections Exclusion criteria: History of hemorrhagic disease; Seizure; Drugs that affect on the surgical homeostasis; Anemia (Hb <10); Poor controlled cerebrovascular accident; History of significant CAD; Arrhythmia; Liver or kidney dysfunction; Electrolyte or metabolic abnormalities; COPD; Severe asthma or other severe respiratory disease; History of PUD; Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical field condition. Timepoint: Every 15 minutes. Method of measurement: With table. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative bleeding percent. Timepoint: Every 15 minutes Intraoperatively. Method of measurement: Maximum allowable blood loss formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sudabeh Haddadi
Guilan University of Medical Sciences
Outcome results
None listed